HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars Hagmeyer Selected Research

Noninvasive Ventilation

1/2023Analysis of an Individualised Stepwise Approach to Non-Pharmacological Therapy in COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars Hagmeyer Research Topics

Disease

7Lung Neoplasms (Lung Cancer)
01/2024 - 05/2016
6Neoplasms (Cancer)
09/2022 - 05/2016
5Interstitial Lung Diseases (Interstitial Lung Disease)
12/2021 - 01/2015
5Idiopathic Pulmonary Fibrosis
01/2021 - 01/2015
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 01/2018
3Disease Progression
01/2017 - 01/2015
2COVID-19
01/2024 - 01/2023
2Chronic Obstructive Pulmonary Disease (COPD)
06/2023 - 03/2013
2Asthma (Bronchial Asthma)
06/2023 - 10/2015
2Heart Failure
01/2023 - 01/2017
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2024
1Respiratory Insufficiency (Respiratory Failure)
01/2024
1Emphysema
01/2023
1Sarcoidosis (Schaumann Disease)
12/2021
1Inflammation (Inflammations)
10/2021
1Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
10/2021
1Granuloma
10/2021
1Hypersensitivity (Allergy)
10/2021
1Pleural Effusion (Pleural Effusions)
01/2021
1Hemorrhage
07/2019
1Dyspnea (Shortness of Breath)
04/2018
1Pneumonia (Pneumonitis)
01/2018
1Carcinoma (Carcinomatosis)
09/2017
1Nervous System Diseases (Neurological Disorders)
01/2017
1Amyloidosis
08/2012

Drug/Important Bio-Agent (IBA)

4Oxygen (Dioxygen)IBA
01/2024 - 04/2018
3pirfenidoneIBA
01/2016 - 01/2015
3nintedanibIBA
01/2016 - 01/2015
2SteroidsIBA
10/2015 - 01/2015
1AntigensIBA
10/2021
1Circulating Tumor DNAIBA
01/2021
1A 17 (A-17)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1LigandsIBA
01/2021
1Apoptosis Regulatory ProteinsIBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1Clostridium perfringens epsilon-toxinIBA
12/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Methylnitronitrosoguanidine (MNNG)IBA
01/2019
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1Kelch-Like ECH-Associated Protein 1IBA
01/2019
1L 644711 (B-3(+))IBA
01/2018
1Opioid Analgesics (Opioids)IBA
01/2017
1Antifibrotic AgentsIBA
01/2016
1prednylidene (Pred)IBA
01/2016
1Amyloidogenic ProteinsIBA
08/2012

Therapy/Procedure

14Therapeutics
03/2024 - 08/2012
3Lymph Node Excision (Lymph Node Dissection)
09/2022 - 09/2017
3Surgical Instruments (Clip)
12/2021 - 07/2019
1Drug Therapy (Chemotherapy)
03/2024
1Artificial Respiration (Mechanical Ventilation)
01/2024
1Extracorporeal Membrane Oxygenation
01/2024
1Respiratory Therapy (Therapy, Respiratory)
06/2023
1Noninvasive Ventilation
01/2023
1Cannula
01/2023
1Continuous Positive Airway Pressure
01/2023
1Punctures
01/2021
1Genomic Medicine
07/2020
1Contraindications
01/2018
1Radiotherapy
01/2018
1Chemoradiotherapy
05/2016
1Duration of Therapy
01/2016
1Aftercare (After-Treatment)
01/2016
1Nebulizers and Vaporizers (Inhaler)
10/2015
1Catheters
03/2013